NCCN 2021 Virtual Congress: Hematologic Malignancies™
Thursday, October 14, 2021 – Saturday, October 16, 2021
NCCN Virtual Congress registration fees include:
Attention NCCN Member Institution Professionals!
NCCN is offering complimentary registrations to healthcare professionals employed at our NCCN Member Institutions. For immediate access to this discount code and to continue your complimentary registration, please login to the NCCN Member Portal.
Members of the Media: Please contact Rachel Darwin.
New format this year! The event has expanded to three days of interactive presentations for a variety of hematologic malignancies. Co-chairs Ranjana H. Advani, MD, Stanford Cancer Institute, and Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center,
will lead expert discussions on the latest advances, updates to the NCCN Guidelines®, and unique and challenging patient cases.
Agenda topics include:
This program is approved for AMA PRA Category 1 Credit™ for physicians and will award contact hours for nurses, pharmacists, and other health care professionals.
Visit the NCCN Virtual Exhibition Hall and Patient Advocacy Pavilion! Congress attendees can participate in live chats, download resources and videos, attend product showcases, and set up one-on-one meetings with exhibitors.
Supported by educational grants from AstraZeneca; Daiichi Sankyo; Gilead Sciences, Inc. and Kite, A Gilead Company; GlaxoSmithKline; Novartis; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Pfizer Inc.; Seagen Inc. (formerly Seattle Genetics, Inc.); and Takeda. This educational activity is supported by a medical education grant from Karyopharm® Therapeutics. This activity is supported by independent medical education grants from ADC Therapeutics, Pharmacyclics LLC and Janssen and Jazz Pharmaceuticals. This activity is supported by an independent educational grant from Merck & Co., Inc.
Gold Level Sponsors
Silver Level Sponsors
Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc.
Bronze Level Sponsors
Karyopharm Therapeutics, Inc.
Organizations who are interested in supporting NCCN CE programs are encouraged to contact Lisa Perfidio.
Sponsorship and exhibit opportunities are available. For more information, contact Jennifer Tredwell.
The NCCN 2020 Virtual Congress: Hematologic Malignancies™ and NCCN Virtual Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™ were held October 8 – 10, 2020. These programs focused on updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®); new, emerging and novel therapeutic agents; advances in cancer care; and the practical management of patients with hematologic malignancies.
View Recorded Sessions
Those who attended the virtual events will be able to access session recordings, exhibition hall information, and other features in the Pathable platform through August 2021. Please email email@example.com with questions.
Save the dates!NCCN 2022 Annual Congress: Hematologic Malignancies™